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ABSTRACT 
The traditional system of medicinal plants have been found to possess significant anti-inflammatory, antibacterial, anti-fungal, anti-diabetic, 
analgesic properties etc. Plant-derived drugs are used to cure mental illness, skin diseases, tuberculosis, diabetes, jaundice, hypertension, and 
cancer. Wedelia Trilobata belongs to family Asteraceae. Leaf, stem, and flower of Wedelia trilobata show anti-microbial, anti-oxidant and anti-
inflammatory activity, analgesic activity. Phytochemical screening of the extract has been reported to show the presence of tannins, cardiac 
glycosides, flavonoids, terpenoids, phenols, saponins, and coumarins. Wedelia Trilobata is also used in reproductive problems, amenorrhea, 
chest cold, dry cough, and fever. The present review aims to the study was phytoconstituents, biological and pharmacological activities of 
Wedelia trilobata. This study suggested a possible use of Wedelia trilobata as a source of natural medicines as an anti-inflammatory, anti-
oxidant, anti-microbial, hepatoprotective, antidiabetic agents.  
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Introduction: 
The introduction of plant-derived drugs in modern medicine 
has been linked to the uses of plant-derived materials as an 
indigenous cure in the traditional system of medicine. Some 
of the plants have been used for the treatment of 
antibacterial, antifungal, anticancer, anti-diuretic, anti-
inflammatory, anti-diabetic medicines at a lower cost and 
lesser side effects than marketed drugs. Various chemical 
constituents have been isolated from medicinal plants. Some 
plant-derived drugs have been used to various diseases like 
mental illness, skin diseases, tuberculosis, diabetes, jaundice, 
hypertension, cancer etc1. 
Wedelia trilobata belongs to family Asteraceae is a highly 
resistant, creeping, perennial plant, with succulent stems. 
Wedelia trilobata is also known as Trailing daiay trilobata2. It 
has a very old tradition of wide medicinal use it a high 
reputation in Ayurveda, Unani, Siddha, and Traditional 
Chinese medicine and also in traditional systems of healing 
in the Carribean, Central and South America. The extracted 
essential oil of Wedelia trilobata has been found to act itself 
as an antioxidant, antibacterial, antifungal, anti-
inflammatory, cough relieving agent, hepatoprotective, 
febrifuge, immuno-stimulatory and analgesic agent. The 
present review aims to address the ethnopharmacological 
uses, phytochemical constituents and reported 
pharmacological activity of Trailing daisy trilobata3. 
Description of Wedelia trilobata: 
Habitat: A weed of urban bushland, closed forest margins, 
open woodland, waterways, lake margins, wetlands, 
roadsides, disturbed sites, waste areas, vacant lots and 
coastal sand dunes in tropical and sub-tropical regions. It 
may also encroach into lawns, footpaths, and parks from 
nearby gardens. 
Geographical Distribution:  Native to India, A.P, Chittor 
district,  Mexico, Central America (i.e. Belize, Costa Rica, 
Guatemala, Honduras, Nicaragua and Panama) the and 
throughout the Caribbean, where it is noted as a weed in 
Trinidad, Puerto Rico, the Dominican Republic, Jamaica, 
Panama and tropical South America(i.e. French Guiana, 
Guyana, Surinam, Venezuela, Brazil, Bolivia, Colombia, 
Ecuador, and Peru). Naturalized in South Africa, Florida, 
Louisiana, Hawaii, Puerto Rico, and the Virgin Island. 
Escaped in many tropical regions of the world including 
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Australia (south-eastern Queensland and north-eastern New 
South Wales). The Pacific Island (i.e. American Samoa, the 
Cook Island, Fiji, French Polynesia, Guam, Kiribati, the 
Marshall Islands, Nauru, Niue, New Caledonia,  Palau, 
Western Samoa, Tonga, and Hawaii), Malaysia, Indonesia, 
Thailand, India, Papua New Guinea. 
Taxonomical Classification: 
 Domain: Eukaryota 
 Kingdom: Plantae 
 Phylum: Spermatophyta 
 Subphylum: Angiospermae 
 Class: Dicotyledonae 
 Oder: Asterales 
 Family: Asteranceae 
 Genus: Sphagneticola  
Species: Sphagneticola trilobata  
Vernacular Names: 
Telugu: Guntagalagara. 
English: Bay Biscayne creeping-oxeye.  
Hindi: Pilabhangara, Bhangra. 
Tamil: Manjalkarilamkanni, patalai kavyantakara.  
Malayalam: Mannakkannunni. 
Kannada: Gargari, kalsarji. 
Synonyms: 
                  Wedelia trilobata(Rich.) Bello  
Complaya trilobata(L.)  
Strother, Silphium trilobatuml.,  
Thelechitonia trilobata(L.) H.Rob. & Cuatrec.,  
Wedelia carnosa Rich.,  
 
Figure: 01 Sphagneticola trilobata 
Pharmacological Activities  
1. Anti-inflammatory Activity: 
Meena et.al (2011) investigated four herbal drugs used in 
traditional Medicine including Wedelia tribolata on the anti-
inflammatory activity. They reported that all the extracts 
reduced croton oil-induced ear dermatitis. Results suggested 
that lipophilic extracts are potential source was found to 
possess have significant anti-inflammatory activity4. 
Maldini et.al (2009) studied anti-inflammatory activity using 
in-vitro models such as albumin denaturation and heat-
induced hemolysis. An ethanol extract of Wedelia trilobata 
demonstrated anti-inflammatory activity, vice suppression of 
lipopolysaccharide-induced cytokine and nitric oxide 
production in peripheral blood mononuclear cells5. 
2. Anti-microbial: 
Maori et.al. (2009)  conducted a study on Anti-microbial 
activity of  Wedelia trilobata, by using Disc- diffusion method. 
The activity of curd extract from Wedelia trilobata against 
gram-positive, gram-negative bacteria, yeast, and fungi was 
evaluated. The n-hexane extract showed antibacterial 
activity against Bacillus subtilis, Mycobacterium smegmatis, 
and Pseudomonas aeruginosa, Salmonella group C, S 
Paratyphi and Shigella sonnei. The aqueous extract was 
active only against salmonella group C, inactive against other 
tested bacteria. None of the tested extracts showed biological 
activity against yeast and fungi6. 
Mandal et.al. (2005) conducted a study on the antimicrobial 
activity of Wedelia trilobata. Aqueous extract of leaf, stem, 
flower inhibited the growth of all the bacterial isolates, but 
the extracts did not show any similar significant effect on 
fungi isolates. The leaf extract showed more potent activity 
against Pseudomonas aeruginosa, E.coli, Pseudomonas. 
fluorescens, Xanthomonas oryzae Proteus Vulgaris.oryzae, 
Xanthomonas. axanopodis Proteus Vulgaris.malvacearum 
moderately inhibited the Clavibacter minchiganensis sub sp. 
Minchiganesis but less activity was observed on 
Staphylococcus aureus. All the extracts exhibited less activity 
on all species of Fusarium and Aspergillus7. 
3. Analgesic:  
Suresh Kumar et.al. (2007) conducted a study on Wedelia 
trilobata by acetic acid-induced writhing method and hot 
plate assay to assess analgesic activity in mice. It was found 
that the extract caused an inhibition of the writhing response 
induced by acetic acid a dose depended manner (500mg/kg). 
The results reflect analgesic effects and the therapeutic 
efficacy of the extract in animal models was comparable with 
that of standard drugs such as aspirin and morphine8. 
Teerapol srichana et.al. (2014) conducted a study in mice on 
the analgesic activity of ethanol extract of  Wedelia trilobata 
by the acetic acid-induced writhing method. The extract 
showed dose depended (500mg/kg)  blocking of writhing 
response. kaurenoic acid(10mg/kg) obtained from Wedelia 
trilobata inhibited over nociception, acute carrageenin, & 
PGE2 induced complete Freund's adjuvant (CFA)  and 
chronic induced mechanical hyperalgesia. The results reflect 
analgesic effects and therapeutic efficacy of the extract on 
animal models which are comparable with that of standard 
drug aspirin9. 
4. Hepatoprotective activity:  
Karamegam et.al.(2008) conducted a study on ethanolic leaf 
extract of Wedelia trilobata against carbon tetrachloride CCl4 
induced acute hepatotoxicity in rats. There was shown a 
significant reduction (P<0.05) in the levels of protein, 
bilirubin and organ weight including liver, heart, left lung, 
spleen, and kidney without any significant changes in body 
weight. The treatment of ethanol leaf extract showed a dose-
dependent reduction of CCl4 induced elevated serum levels 
of enzyme activities with a parallel increase in total protein & 
bilirubin10. 
Lin et.al. (1994) investigated the hepatoprotective effect of 
Wedelia trilobata. Acute hepatitis was induced by three 
hepatotoxins, such as carbon tetrachloride, acetaminophen 
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in mice and galactosamine in rats after treatment with W. 
trilobata (300 mg/kg) a reduction in the elevated serum 
glutamate oxaloacetate transaminase and glutamate pyruvic 
transaminase levels was observed at 24 hours after 
hepatotoxins were administration. It was concluded that 
Wedelia trilobata has a definite hepatoprotective effect 
against liver injuries11. 
5. Anti-diabetic: 
Sunita Kanikaram et.al. (2018) determined the anti-diabetic 
activity of crude extracts of Wedelia trilobata along with 
Brassica oleraceae by applying in vitro α-amylase inhibition 
method. The methanol extract of Wedelia trilobata 
significantly showed DPPH inhibition with IC50 20 µg/mL and 
in vitro α-amylase inhibition IC50 50µg/mL. It was concluded 
that methanol extract of Wedelia trilobata can be a potential 
source of anti-oxidant and as good anti-diabetic12. 
Pradeep et .al.(2014) conducted a study on methanolic 
extract of Wedelia trilobata using in- vitro glucose diffusion, 
α-amylase, α-glycosidase &  angiotensin I  converting enzyme 
inhibition method. They showed an inhibitory effect on the 
α-glucosidase enzyme. Glucose movement from sealed 
dialysis tube to an external solution was inhibited by Wedelia 
trilobata extract. The methanol extract of Wedelia trilobata 
inhibited the rabbit lung angiotensin I converting 13 enzyme 
with Ic50 of 30µg/mL. Biological and pharmacological 
activities are explained in Table.2. 
 
Table 2: Biological and pharmacological activities reported 
 
 
                Activity     Method Parameters Reference 
 
1.Anti inflammatory 
activity 
 
 
   
 
 
  
 
 
 
                       
 
                       
a. In vitro Heat-induced 
albumin denaturation. 
Albumin denaturation 
 
GovindappaM.Naga (et.al  
2011)14. 
b. In vivo Croton oil-induced 
ear oedema in rats. 
 
Inhibition of plasma 
extravasations and neutrophil 
migration 
Giovanafucina(et.al 2016)15. 
 
c. In vitro Heat-induced 
albumin denaturation and red 
blood cell membrane 
denaturation. 
protein denaturation 
 
 
 
Naga sravya s (et.al 2011)16. 
 
 
d. In vitro Lipo poly 
saccharide: (LPS) induced 
nitric oxide  
A cell as well as cytotoxic 
activity 
  
Nguyen Phuong thao (et.al 
2019).17 
 
e. In vitro nuclear staining and 
DNA fragmentation assays. 
Induces apoptosis in MEG-01 
cells 
Satish Kumar Murari 
(et.al2016).18 
 
2. Antimicrobial 
               
 
 
 
                 
 
 
                   
a. In vitro disc diffusion 
method. 
               
It shows a zone of inhibition on 
Staphylococcus aureus, X. 
oryzaepv. Oryzae  
Taddei A. (et.al 1999).19 
 
 
b. In vitro Agar well as disk 
diffusion method and 
minimum inhibitory 
concentration method  
A moderate inhibitory activity 
against all bacterial species 
with zones of inhibition 
 
Diptanu biswas (et.al 
2013).20 
 
 
c. In vitro  antimicrobial 
activity of  n-hexane inhibited 
by bacillus subtilis 
Inhibited the growth of  bacillus 
subtilis   shows yeast and fungi 
 
Antonietataddei (et.al 
2006).21 
 
d. In vitro agar disc diffusion 
method 
Human pathogenic bacteria 
was tested  
J. Chethan (et.al 2012).22 
f. In vivo broth microdilution 
method in dogs. 
             
Activity against bacteria 
Escherichia coli in human and 
dog  skin  
Ana greiceborbaleite (et.al 
2019).23 
     
4.Analgesic activity  
  
              
 
 
 
a. In vivo Kaurenoic acid-
induced, PGE2 method in mice. 
Blocked the writhing response   Suresh kumar (et.al 2007).24 
 
b. In vivo isoprenaline-induced 
myocardial infarction in rats                
Blocking the mitochondrial 
lipid peroxidation (LPO). 
Rangasamy Rajesh (et.al 
2007).25 
c. In vivo acetic acid-induced 
writhing method and hot plate 
in mice.                  
 Blocking writhing response  S.Bhama (et.al 2007).26 
   5.  
Hepato protective 
activity 
 
 
a. In vivo   Croton oil-induced 
ear dermatitis in rats 
Inhibition of  writhing response  Meena (et al 2011).27 
 
b. In vivo CCl4 induced acute 
hepatotoxicity in rats          
Serum aspartate transaminase 
(AST) and alanine 
transaminase (ALT)  
Karmegam (et al 2008).28 
 
             
6. Anti diabetic 
 
  
a. In vitro α-amylase inhibition 
method.               
IC50 of α-amylase shows Insulin 
dysfunction. 
Sunita Kanikaram (et al 
2018).29 
b. In vitro Heat-induced 
albumin denaturation 
Protein denaturation. Pradeep (et.al.2014). 30 
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Phytochemical Constituents Reported in Wedelia 
trilobata: 
The secondary metabolites from these plants 
mainly include terpenoids, flavonoids, and polyacetylenes as 
well as steroids. The leaves and stem contain eudesmanolide 
lactones, Luteolin, and kaurenoic acid. Different classes of 
phytoconstituents such as sesquiterpenoids, triterpenoids, 
and diterpenoids have been reported from the aerial parts, 
and the flower of Trailing daisy trilobata shown the presence 
of sterols, flavonoids, Benzene derivatives. Most constituents 
of oils belong to the large group of terpenes. The essential oil 
obtained from the leaves of Wedelia trilobata was analyzed 
by GC/MS. Which shows α-pinene (above 30%), α-
phellandrene (17.4%) and limonene (16.3%) as major 
components Phytochemical constituents are explained in 
Table.3
 
Table 3: Phytochemical Constituents reported in Wedelia trilobata 
Plant part Phytoconstituents Reference 
Aqueous extract of aerial parts   Terpenoids, flavonoids, 
polyacetylenes and Steroids. 
Sadananda (et.al 2011).31 
 
 Aqueous extract of Leaves and 
stem 
Eudesmanolide lactone, 
luteolin and Arachidonic acid. 
Sharanappa (et.al 2011).32 
 Ethanol extract of aerial parts Sterols, flavonoids, Benzene 
derivatives. 
Guaratini ( et.al 2016).33 
A methanol extract of Leaves  Terpenes  Hoepers (et. al. 2016).34 
 Essential oils obtained from leaves 
analyzed by GC/MS  
α -pinene. α -phellandrene. 
Limonene 
Govindappa et.al. (2011).35 
 
Conclusion:   
Presently there is an increase in the significance of 
herbal medicines with amplified laboratory investigations of 
biological and pharmacological properties. The plant 
Wedelia trilobata emerged as a good source of medicine with 
anti-inflammatory anti-microbial, analgesic, anti-oxidant, 
hepatoprotective and anti-diabetic properties. A large 
number of phytoconstituents have been isolated and 
identified from different parts of Wedelia trilobata which 
include flavanoids, triterpenoids luteolin, arachidonic acid, 
sterols and other constituents of the essential oil reported 
are α-pinene, α-phellandrene and limonene. The current 
review on Wedelia trilobata can be a good source of 
information for further research to explore their full 
therapeutic activity. 
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